Delivery Order SPE2DB24D6039-SPE2DB25FLEGU

Award Date 5/29/25
Potential Completion Date 5/30/25
Potential Value $5.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 0.5 mL VAXELIS vaccine syringes, with a ceiling value of $2,557.92 and a period of performance through May 7, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the VAXELIS vaccine syringe 0.5ML, with a ceiling value of $1,278.96 and an ultimate completion date of April 14, 2025. The contract is a Firm Fixed Price Delivery Order, which is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,557.92 firm fixed-price contract is for the delivery of the VAXELIS vaccine syringe 0.5 ML. The award has an ultimate completion date of February 4, 2025. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the VAXELIS vaccine syringe (0.5 mL). The contract has a ceiling value of $2,557.92 and a completion date of February 4, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VAXELIS vaccine syringes, 0.5 mL, with a ceiling value of $3,289.05 and a period of performance through March 6, 2025. The contract is a firm-fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,278.96, is for the delivery of VAXELIS vaccine syringes (0.5 mL) and has a completion date of February 12, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. In addition to this delivery order, AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,479.45, is for the delivery of the VAXELIS vaccine syringe (0.5 mL) and has a period of performance through March 31, 2025. The contract is a firm-fixed-price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VAXELIS vaccine syringes, 0.5 ML, with a ceiling value of $4,034.60 and a completion date of May 2, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,394.80, is for the delivery of VAXELIS vaccine syringes (0.5mL) and has an ultimate completion date of March 25, 2025. The contract is a firm fixed-price agreement and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VAXELIS vaccine syringes. The $3,015.25 firm fixed-price contract has an ultimate completion date of October 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty...
  • SPE2DB24D6039
    Indefinite Delivery Contract
  • SPE2DB24D6039-SPE2DB25FLEGU
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the VAXELIS vaccine syringe 0.5ML, with an ultimate completion date of May 30, 2025 and a ceiling value of $5,488.46. The contract is not set-aside and is an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 8/28/25, 10:00 AM